돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2073167생성일: 2026년 10월 26일

Indomethacin → 1,8-Naphthyridin-2(1H)-one, 3-methyl-1-phenyl-

https://huagongshe.com/reaction/2073167

반응식

참여 물질

역할이름HCID투입량
반응물IndomethacinHCID 3715—
반응물PropranololHCID 4946—
반응물PyrilamineHCID 4992—
생성물1,8-Naphthyridin-2(1H)-one, 3-methyl-1-phenyl-HCID 3087761—

반응 단계

The sensitized guinea pigs are injected i.v. with 1 mg/kg propranolol, 5 mg/kg indomethacin and 2 mg/kg mepyramine given together in a volume of 1 ml/kg. Fifteen minutes later the animals are challenged with nebulized ovalbumin. Test compounds are administered orally 2 hours before challenge with ovalbumin. Suppression of anaphylactic bronchospasm is expressed as a percent inhibition of the peak increase in intratracheal pressure by comparison to a vehicle-treated control group. In this procedure, 3-methyl-1-phenyl-1,8-naphthyridin-2(1H)-one (referred to as Compound A hereinafter) provided a 96% inhibition at a dose of 5 mg/kg p.o.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US04916131
출처 데이터셋uspto-grants-1990_04
ORD IDord-1016a1bb331d436f8ac495eb61a53431
출처 메모uspto-grants-1990_04